This podcast focuses on the surgical site infection reduction bundle as part of the ERAS guidelines that was first published in 2016 and updated in 2019, and the 2020 vulvar and vaginal surgeries ERAS guidelines.

Before we dive into the SSI reduction bundle, we want to highlight the importance of patient education and participation in any ERAS protocol. Pre-operative education and psychological preparation is critical. Written information was determined to be superior to verbal in a randomized clinical trial in gynecologic oncology surgery.

2023-2024 SGO ERAS Subcommittee Members and Speakers:
Lee-may Chen, MD; Subcommittee Lead and Moderator
Nawar Latif, MD, MPH, MSCE
Collin Sitler, DO
Brenna Swift, MD, MASc, MSc, FRCSC

This is the last of the three-part podcast series, Keeping up with the Chemos on Trabectedin and Doxorubicin. Our multidisciplinary panel will discuss the challenges with patient monitoring while on Trabectedin and Doxorubicin. When to dose adjust and hold or even discontinue Trabectedin and Doxorubicin. Once again, the podcast ends with take home points for patient monitoring and side effects while on Trabectedin and Doxorubicin.  

2023-2024 SGO Chemotherapy and Targeted Therapies Subcommittee Members and Moderators:
Tracilyn Hall, MD
Jennifer MacDonald, PharmD, BCOP

Speakers:
Sminu Bose, MD
Joshua Cohen, MD 
Claire Marie Mach, PharmD, BCOP    

This is the second of the three-part podcast series, Keeping up with the Chemos on Trabectedin and Doxorubicin. Our multidisciplinary panel will discuss the important information about the drug preparation and administration of Trabectedin and Doxorubicin. Focusing on oral dosing, infusion pump setup, lab examinations, and patient education. The session ends with general take home points on administration and toxicity prevention interventions.

2023-2024 SGO Chemotherapy and Targeted Therapies Subcommittee Members and Moderators:
Tracilyn Hall, MD
 Jennifer MacDonald, PharmD, BCOP

Speakers:
Sminu Bose, MD
Joshua Cohen, MD 
Claire Marie Mach, PharmD, BCOP    

This is the first of the three-part podcast series, Keeping up with the Chemos on Trabectedin and Doxorubicin. After going over some general information on Trabectedin and Doxorubicin including when to use the drug, checking patient performance status, toxicity, and line of therapy and treatment option for recurring metastasis disease. The multidisciplinary panel will discuss dosing and drug preparation for giving Trabectedin and Doxorubicin. The session wraps up with some key take home points on Trabectedin and Doxorubicin.  

2023-2024 SGO Chemotherapy and Targeted Therapies Subcommittee Members and Moderators:
Tracilyn Hall, MD
Jennifer MacDonald, PharmD, BCOP

Speakers:
Sminu Bose, MD
Joshua Cohen, MD 
Claire Marie Mach, PharmD, BCOP    

Episode two of the Radiation Therapy podcast series discusses treatment of Oligometastatic disease, re-irradiation and role of palliative radiation, utilization of SBRT, introduction to proton therapy and mitigation of radiation-associated toxicities.

Host:
Mian M. Shahzad, MD, PhD
Gynecologic Oncologist, H. Lee Moffitt Cancer Center

Guest Speaker: 
Michael Montejo, MD
Radiation oncologist, H. Lee Moffitt Cancer Center 

This episode is part 1 of the Immunotherapy podcast series, which reviews immune-checkpoint inhibitors encountered in the gynecologic oncology setting, common immunotherapy toxicities and patient counseling on them, as well as the basic treatment course for patients with high-grade toxicities.

Moderator:
Karin K. Shih, MD
Gynecologic Oncologist & Assistant Professor - Zucker School of Medicine at Hofstra/Northwell

Speakers: 
Erin Zacholski, PharmD, BCOP 
Assistant Professor - VCU School of Pharmacy
Clinical Pharmacy Specialist, Gynecologic Oncology -  VCU Health Massey Cancer Center
 
Sarah Hayward, PharmD, BCOP
Clinical Pharmacy Specialist, Gynecologic Oncology - OU Health Stephenson Cancer Center

This episode is part 1 of the Radiation Therapy podcast series, which looks to review and address the basic fundamentals of radiation therapy in the gynecologic oncology setting.

Host: Mian M. Shahzad, MD PhD (Gynecologic Oncologist; H. Lee Moffitt Cancer Center)

Guest Speaker: Michael Montejo, MD (Radiation oncologist; H. Lee Moffitt Cancer Center) 

This is the last of the three-part podcast series, Keeping up with the Chemos on Trametinib. Our multidisciplinary panel will discuss the challenges with patient monitoring while on Trametinib. When to dose adjust and hold or even discontinue Trametinib. Once again, the podcast ends with take home points for patient monitoring and side effects while on Trametinib. 

2023-2024 SGO Chemotherapy and Targeted Therapies Subcommittee Members and Moderators:
Tracilyn Hall, MD
Jennifer MacDonald, PharmD, BCOP

Speakers:
Christina M. Davis, PharmD, BCOP
David M. Gershenson, MD 
Rebecca L. Porter, MD, PhD 

This is the second of the three-part podcast series, Keeping up with the Chemos on Trametinib. Our multidisciplinary panel will discuss the important information about the drug preparation and administration of Trametinib. Focusing on oral dosing, lab examinations, prophylactic management of skincare reactions, and patient education. The session ends with general take home points on administration and toxicity prevention interventions.

2023-2024 SGO Chemotherapy and Targeted Therapies Subcommittee Members and Moderators:
Tracilyn Hall, MD
Jennifer MacDonald, PharmD, BCOP

Speakers:
Christina M. Davis, PharmD, BCOP
David M. Gershenson, MD 
Rebecca L. Porter, MD, PhD 

This is the first of the three-part podcast series, Keeping up with the Chemos on Trametinib. After going over some general information on Trametinib including mutation status considerations, baseline lab testing, ocular toxicity, and line of therapy. The multidisciplinary panel will discuss dosing and drug preparation for giving Trametinib. The session wraps up with some key take home points on Trametinib.

2023-2024 SGO Chemotherapy and Targeted Therapies Subcommittee Members and Moderators:
Tracilyn Hall, MD
Jennifer MacDonald, PharmD, BCOP

Speakers:
Christina M. Davis, PharmD, BCOP
David M. Gershenson, MD 
Rebecca L. Porter, MD, PhD